You are here

Europe: Britain's FTSE lifted by pharma firms after Pfizer deal falls apart

Thursday, April 7, 2016 - 00:33

pharm070416.jpg
Pharmaceuticals companies helped Britain's top share index to move higher on Wednesday as Pfizer pulled out of a deal for Allergan, prompting speculation over other merger and acquisition activity in the sector.

[LONDON] Pharmaceuticals companies helped Britain's top share index to move higher on Wednesday as Pfizer pulled out of a deal for Allergan, prompting speculation over other merger and acquisition activity in the sector.

US drugmaker Pfizer terminated its US$160 billion agreement to acquire Botox maker Allergan in a major victory for US President Barack Obama's drive to thwart tax-dodging corporate mergers.

The news lifted shares in Shire and AstraZeneca by 5.2 per cent and 4.5 per cent respectively, the top gainers on Britain's FTSE 100.

While it is unclear the extent to which a bid from Pfizer for a UK-listed drugmaker would fall foul of new US Treasury rules to curb so-called tax inversion deals, traders said the sector was rallying on the possibility that British pharma companies might be back in play.

sentifi.com

Market voices on:

"The possibility now is that Pfizer goes shopping again, and you might be prepared to develop a case that maybe a firm like Shire becomes the bid target," said Chris Beauchamp, market analyst at IG. "The implications of the new rules would have to be worked out, but if you've got cash sloshing around the sector, people are wondering who will benefit."

Several broker notes, including one from Credit Suisse, said Shire's bid for Baxalta is likely go ahead despite the new ruling. "It looks as though Shire will still be able to move forward with the Baxalta deal despite the rules," Mr Beauchamp added.

The FTSE 100 was up 70.40 points, or 1.2 per cent at 6,161.63 points at its close, with healthcare stocks adding about 13 points to the index.

Airlines were the biggest fallers, led lower by easyJet . The budget airline fell 3 per cent after the release of its latest passenger statistics.

Traders said the figures showed that the company was underperforming the likes of Ryanair, which produced stronger figures last month. "Budget airline easyJet's latest figures disappointed investors," AJ Bell Investment Director Russ Mould said in a note. "Passenger numbers rose in March but the load factor fell after the airline was forced to cancel hundreds of flights, principally due to strike action in France." British Airways owner IAG was down 2.6 per cent.

Miner Glencore also fell, down 1.2 per cent after agreeing to sell 40 per cent of its agricultural business to Canada's state pension fund for US$2.5 billion in a move to cut debt. "The more assets Glencore disposes of, the more shareholders will begin to weigh up the benefits to the balance sheet versus the negatives of lost future revenue," Jasper Lawler, market analyst at CMC Markets, said in a note.

REUTERS

Nespresso
Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at btsub.sg/btdeal

Powered by GET.comGetCom